CapsoVision, Inc. (CV) Stock

CapsoVision, Inc. (CV) is a Healthcare stock trading at $6.62 (as of 2026-06-18), with a market capitalization of $338.75M and a trailing P/E of 5.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Medical‑technology company developing advanced capsule endoscopy systems (CapsoCam Plus, CapsoCam Colon) and AI-enabled imaging platforms for gastrointestinal diagnostics

Valuation — source: SEC EDGAR (first-party)
Price$6.62
Market Cap$338.75M
P/E Ratio5.5
EV / EBITDA-13.3
Price / Book17.77
Price / Sales26.49
DCF Value (model)$-7.84
DCF Upside vs Price-218.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$13.55M
Net Margin-186.8%
Return on Equity-133.4%
Current Ratio4.57
Revenue Growth (YoY)15.3%
EPS Growth (YoY)-89.5%
FCF Growth (YoY)13.4%
Financial Health — source: SEC EDGAR
Altman Z-Score25.29 (safe)
Valuation vs Sector & Industry
Stock P/E5.5
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-73.8%
vs Industry-82.7%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($9.51M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOKang Huai Wang
Employees90
CountryUS
IPO Date2001-09-03

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Pacific Biosciences of California, Inc. (PACB)
  • Avanos Medical, Inc. (AVNS)
  • NeuroPace, Inc. (NPCE)
  • Bioventus Inc. (BVS)
  • OrthoPediatrics Corp. (KIDS)
  • Owlet, Inc. (OWLT)
  • Alpha Tau Medical Ltd. (DRTS)
  • RxSight, Inc. (RXST)
CV earnings history · CV institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.